18 research outputs found
In vitro evaluation on a model of Blood Brain Barrier of Idebenone loaded solid lipid nanoparticles.
Nanotechnological Approach to Increase the Antioxidant and Cytotoxic Efficacy of Crocin and Crocetin
AbstractCrocin and crocetin are two interesting constituents of saffron (Crocus sativus) that possess important biological activities. Their use as therapeutic agents is strongly compromised by a scarce stability, poor absorption, and low bioavailability. Therefore, to improve these unfavorable features, the aim of the present work has been to apply a nanotechnological approach based on the formulation of solid lipid nanoparticles containing crocin and crocetin. Solid lipid nanoparticles were formulated according to crocin and crocetin chemical properties, using a variation of the quasi-emulsion solvent diffusion method to formulate crocin-solid lipid nanoparticles, while crocetin-solid lipid nanoparticles were prepared following the solvent diffusion method. Morphology and dimensional distribution of solid lipid nanoparticles have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively, while the effect of drug incorporation versus time has been studied by Turbiscan technology. In order to verify the role of the nanotechnological approach on the biological activities of crocin and crocetin, the antioxidant and antiproliferative effects of these carotenoids once incorporated in lipid nanoparticles have been evaluated. For this aim, the oxygen radical absorbance capacity assay and the MTT test were used, respectively.The results pointed out the formulation of nanometric dispersions endowed with high homogeneity and stability, with an encapsulation efficiency ranging from 80 (crocetin-solid lipid nanoparticles) to 94% (crocin-crocetin). The oxygen radical absorbance capacity assay evidenced an interesting and prolonged antioxidant activity of crocin and crocetin once encapsulated in solid lipid nanoparticles, while the nanoencapsulation strategy showed a different mechanism in ameliorating the cytotoxic effect of these two substances
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release
Aims: The aim of this study was to explore the potential of novel nanoparticles (NPs)
intended for topical administration of the hydrophilic antioxidant Glutathione and the
lipophilic Idebenone. Glutathione was introduced into the NPs using two approaches: i)
covalently bonded to Chitosan; ii) physically complexed with Idebenone and
Sulfobutylether--cyclodextrin.
Methodology: NPs were formulated using the ionic gelation technique, by dissolving the
polysaccharide-forming matrix (Chitosan, Glycol chitosan, Glutathionyl Chitosan) in water
or in slightly acidic solution. Idebenone was physically entrapped whereas glutathione was
either physically entrapped or covalently bonded to chitosan.
Physicochemical characterization of the resulting NPs included size, zeta potential
measurements, antioxidant association efficiency, differential scanning calorimetry (DSC)
and stability studies. Antioxidants in vitro release from the most stable NPs was assessed
with Franz diffusion cells, and the in vitro antioxidant activity was evaluated by the 2,2- diphenyl-1-picrylhydrazyl (DPPH) radical test. NP cytotoxicity was assessed on
immortalized human keratinocytes (HaCaT) cell line. Results: The NPs showed smaller particle size in acidic solution than in aqueous
medium, whereas zeta potential values were always positive, irrespective of the medium.
Stability studies led to the choice of the aqueous formulation where Glutathione was
covalently bonded to Chitosan for this study. DSC highlighted amorphization of Idebenone
in these NPs. In vitro release studies showed that only Idebenone was released from the
NPs. The antioxidant activity test revealed a strong effect (close to 100%) of Idebenone
loaded into NPs while its aqueous solution showed no activity. No cytotoxicity in human
keratinocytes was observed for the investigated NPs.
Conclusion: The results of this study suggest that Idebenone can be loaded into a
hydrophilic delivery system without organic solvents, often used for its solubilization,
possessing high antioxidant activity. Therefore, these nanocarriers represent a promising
strategy for the design of formulations for topical treatments with antioxidants
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release
Aims: The aim of this study was to explore the potential of novel nanoparticles (NPs) intended for topical administration of the hydrophilic antioxidant Glutathione and the lipophilic Idebenone. Glutathione was introduced into the NPs using two approaches: i) covalently bonded to Chitosan; ii) physically complexed with Idebenone and Sulfobutylether--cyclodextrin.
Methodology: NPs were formulated using the ionic gelation technique, by dissolving the polysaccharide-forming matrix (Chitosan, Glycol chitosan, Glutathionyl Chitosan) in water or in slightly acidic solution. Idebenone was physically entrapped whereas glutathione was either physically entrapped or covalently bonded to chitosan.
Physicochemical characterization of the resulting NPs included size, zeta potential measurements, antioxidant association efficiency, differential scanning calorimetry (DSC) and stability studies. Antioxidants In vitro release from the most stable NPs was assessed with Franz diffusion cells, and the In vitro antioxidant activity was evaluated by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical test. NP cytoxicity was assessed on immortalized human keratinocytes (HaCaT) cell lines.
Results: The NPs showed smaller particle size in acidic solution than in aqueous medium, whereas zeta potential values were always positive, irrespective of the medium. Stability studies led to the choice of the aqueous formulation where Glutathione was covalently bonded to Chitosan for this study. DSC highlighted amorphization of Idebenone in these NPs. In vitro release studies showed that only Idebenone was released from the NPs. The antioxidant activity test revealed a strong effect (close to 100%) of Idebenone loaded into NPs while its aqueous solution showed no activity. No cytotoxicity in human keratinocytes was observed for the investigated NPs.
Conclusion: The results of this study suggest that Idebenone can be loaded into a hydrophilic delivery system without organic solvents, often used for its solubilization, possessing high antioxidant activity. Therefore, these nanocarriers represent a promising strategy for the design of formulations for topical treatments with antioxidants
Mucoadhesive Properties and Interaction with P-glycoprotein (P-gp) of Thiolated-Chitosans and -Glycol Chitosans and Corresponding Parent Polymers: A Comparative Study
The aim of the present work was to compare the mucoadhesive and efflux pump P-glycoprotein (P-gp) interacting properties of chitosan (CS)- and glycolchitosan (GCS)-based thiomers and corresponding unmodified parent polymers. For this purpose, the glycol chitosan-N-acetyl-cysteine (GCS-NAC) and glycol chitosan-glutathione (GCS-GSH) thiomers were prepared under simple and mild conditions. Their mucoadhesive characteristics were studied by turbidimetric and zeta potential measurements. The P-gp interacting properties were evaluated measuring the effects of thiolated- and unmodified-polymers on the bidirectional transport (BA/AB) of rhodamine-123 across Caco-2 cells as well as in the calcein-AM and ATPase activity assays. Although all the thiomers and unmodified polymers showed optimal-excellent mucoadhesive properties, the best mucoadhesive performances have been obtained by CS and CS-based thiomers. Moreover, it was found that the pretreatment of Caco-2 cell monolayer with GCS-NAC or GCS restores Rho-123 cell entrance by inhibiting P-gp activity. Hence, GCS-NAC and GCS may constitute new biomaterials useful for improving the bioavailability of P-gp substrates
Effects of cyberknife radiotherapy treatment of pituitary adenomas
none11nononePuglisi, Soraya; Cotta, Oana Ruxandra; Conti, Alfredo; Pontoriero, Antonio; Messina, Erika; Albani, Adriana; Ferrau, Francesco; Ragonese, Marta; Torre, Maria Luisa; Angileri, Flavio; Cannavo, SalvatorePuglisi, Soraya; Cotta, Oana Ruxandra; Conti, Alfredo; Pontoriero, Antonio; Messina, Erika; Albani, Adriana; Ferrau, Francesco; Ragonese, Marta; Torre, Maria Luisa; Angileri, Flavio; Cannavo, Salvator
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether cyclodextrin based nanoparticles
The aim of this study was to evaluate chitosan (CS)-, glycol chitosan (GCS)- and corresponding thiomer-based nanoparticles (NPs) for delivering dopamine (DA) to the brain by nasal route. Thus, the polyanions tripolyphosphate and sulfobutylether-β-cyclodextrin (SBE-β-CD), respectively, were used as polycation crosslinking agents and SBE-β-CD also in order to enhance the DA stability. The most interesting formulation, containing GCS and SBE-β-CD, was denoted as DA GCS/DA-CD NPs. NMR spectroscopy demonstrated an inclusion complex formation between SBE-β-CD and DA. X-ray photoelectron spectroscopy analysis revealed the presence of DA on the external surface of NPs. DA GCS/DA-CD NPs showed cytotoxic effect toward Olfactory Ensheathing Cells only at higher dosage. Acute administration of DA GCS/DA-CD NPs into the right nostril of rats did not modify the levels of the neurotransmitter in both right and left striatum. Conversely, repeated intranasal administration of DA GCS/DA-CD NPs into the right nostril significantly increased DA in the ipsilateral striatum. Fluorescent microscopy of olfactory bulb after acute administration of DA fluorescent-labeled GCS/DA-CD NPs into the right nostril showed the presence of NPs only in the right olfactory bulb and no morphological tissue damage occurred. Thus, these GCS based NPs could be potentially used as carriers for nose-to-brain DA delivery for the Parkinson's disease treatment